PMID- 37079165 OWN - NLM STAT- MEDLINE DCOM- 20230706 LR - 20230706 IS - 1613-2246 (Electronic) IS - 0021-5155 (Linking) VI - 67 IP - 4 DP - 2023 Jul TI - Galectin-3, a damage-associated molecular pattern, in tears of patients with vernal keratoconjunctivitis. PG - 431-439 LID - 10.1007/s10384-023-00994-9 [doi] AB - PURPOSE: Galectin-3 is a damage-associated molecular pattern (DAMPs), released from damaged or dying cells. In this study, we investigated the concentration and source of galectin-3 in the tears of patients with vernal keratoconjunctivitis (VKC) and evaluated whether the concentration of galectin-3 in tears represents a biomarker of corneal epithelial damage. STUDY DESIGN: Clinical and experimental. METHODS: We measured the concentration of galectin-3 in tear samples from 26 patients with VKC and 6 healthy controls by enzyme-linked immunosorbent assay (ELISA). The expression of galectin-3 in cultured human corneal epithelial cells (HCEs) stimulated with or without tryptase or chymase was investigated by polymerase chain reaction (PCR), ELISA, and Western blotting. We also estimated the concentration of galectin-3 in the supernatants of cultured HCEs induced to necrosis. Finally, we investigated whether recombinant galectin-3 induced the expression of various genes related to cell migration or the cell cycle in HCEs by using microarray analysis. RESULTS: High concentrations of galectin-3 were detected in the tears of patients with VKC. The concentration showed significant correlation with the severity of corneal epithelial damage. Stimulation of cultured HCEs with various concentrations of tryptase or chymase had no effect on the expression of galectin-3. However, high concentrations of galectin-3 were detected in the supernatants of necrotic HCEs. Recombinant human galectin-3 induced various cell migration- and cell cycle-related genes. CONCLUSION: The concentrations of galectin-3 in the tears of patients with VKC may represent a biomarker of the severity of corneal epithelial damage. CI - (c) 2023. Japanese Ophthalmological Society. FAU - Ito, Yousuke AU - Ito Y AD - Juntendo University Graduate School of Medicine, Tokyo, Japan. AD - Department of Ophthalmology, Juntendo University Urayasu Hospital, 2-1-1, Tomioka, Urayasu-shi, Chiba, Japan. FAU - Usui-Ouchi, Ayumi AU - Usui-Ouchi A AD - Department of Ophthalmology, Juntendo University Urayasu Hospital, 2-1-1, Tomioka, Urayasu-shi, Chiba, Japan. FAU - Ebihara, Nobuyuki AU - Ebihara N AD - Department of Ophthalmology, Juntendo University Urayasu Hospital, 2-1-1, Tomioka, Urayasu-shi, Chiba, Japan. ebihara@juntendo.ac.jp. LA - eng PT - Journal Article DEP - 20230420 PL - Japan TA - Jpn J Ophthalmol JT - Japanese journal of ophthalmology JID - 0044652 RN - EC 3.4.21.39 (Chymases) RN - 0 (Galectin 3) RN - EC 3.4.21.59 (Tryptases) RN - 0 (LGALS3 protein, human) SB - IM MH - Humans MH - Chymases/metabolism MH - *Conjunctivitis, Allergic/diagnosis/genetics/metabolism MH - Enzyme-Linked Immunosorbent Assay MH - Galectin 3/genetics/metabolism MH - Tears/metabolism MH - Tryptases/metabolism OTO - NOTNLM OT - Chymase OT - DAMPs (damage-associated molecular patterns) OT - Galectin-3 OT - Tryptase OT - Vernal keratoconjunctivitis EDAT- 2023/04/20 13:41 MHDA- 2023/07/03 06:41 CRDT- 2023/04/20 11:18 PHST- 2022/09/08 00:00 [received] PHST- 2023/02/24 00:00 [accepted] PHST- 2023/07/03 06:41 [medline] PHST- 2023/04/20 13:41 [pubmed] PHST- 2023/04/20 11:18 [entrez] AID - 10.1007/s10384-023-00994-9 [pii] AID - 10.1007/s10384-023-00994-9 [doi] PST - ppublish SO - Jpn J Ophthalmol. 2023 Jul;67(4):431-439. doi: 10.1007/s10384-023-00994-9. Epub 2023 Apr 20.